Document:

exv10w2

Exhibit 10.2

REGISTRATION RIGHTS AGREEMENT

     THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 8, 2008, among
Texas Capital Bancshares, Inc. a Delaware corporation (the “Company”), and the persons identified
on the signature page hereof (referred to collectively herein as the “Purchasers” and each
individually as a “Purchaser”).

R E C I T A L S:

     WHEREAS, this Agreement is made pursuant to the Stock Purchase Agreement (the “Stock Purchase
Agreement”), dated as of September 8, 2008, by and among the Company and certain purchasers of
Shares; and

     WHEREAS, in connection with the consummation of the transactions contemplated by the Stock
Purchase Agreement, the parties desire to enter into this Agreement in order to grant certain
registration rights to the Purchasers as set forth below.

     NOW, THEREFORE, in consideration of the foregoing premises and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

SECTION 1.

GENERAL

     1.1 Definitions. As used in this Agreement, the following terms shall have the
following respective meanings:

     “Affiliate” of any particular Person means any other Person controlling, controlled by
or under common control with such particular person or entity.

     “Closing Date” means the date on which the closing of the transactions contemplated by
the Stock Purchase Agreement occurs.

     “Common Stock” means shares of common stock, $0.01 par value per share, of the
Company.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended, or similar
federal statute, and the rules and regulations of the Commission thereunder, all as the same shall
be in effect at the time.

     “Form S-3” means such form under the Securities Act as in effect on the date hereof or
any successor or similar registration form under the Securities Act subsequently adopted by the SEC
which permits inclusion or incorporation of substantial information by reference to other documents
filed by the Company with the SEC.

 

 

     “Holder” means any Purchaser who holds Registrable Securities and any holder of
Registrable Securities to whom the registration rights conferred by this Agreement have been
transferred in compliance with Section 2.8 hereof.

     “Mandatory Registration” shall have the meaning ascribed to it in Section 2.1(a)
hereof.

     “Person” means any individual, corporation, partnership, joint venture, limited
liability company, business trust, joint stock company, trust or unincorporated organization or any
government or any agency or political subdivision thereof.

     “Register,” “registered,” and “registration” shall refer to a
registration effected by preparing and filing a registration statement in compliance with the
Securities Act and applicable rules and regulations thereunder, and the declaration or ordering of
effectiveness of such registration statement.

     “Registrable Securities” means (a) the Shares; and (b) any Common Stock issued as (or
issuable upon the conversion or exercise of any warrant, right, preferred stock or other security
which is issued as) a dividend or other distribution with respect to, or in exchange for or in
replacement of the Shares held by the Holders provided, however, that Registrable Securities shall
not include any shares of Common Stock (i) which have been sold to the public by a Holder either
pursuant to a registration statement or Rule 144 under the Securities Act; (ii) which have been
sold in a private transaction in which the transferor’s rights under this Agreement are not
assigned in compliance with the terms of this Agreement; or (iii) which may be sold pursuant to
Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144 (or any
successor thereto) under the Securities Act, after taking into account any Holders’ status as an
Affiliate of the Company as determined by counsel to the Company pursuant to a written opinion
letter addressed to the Company’s transfer agent to such effect (provided at least 12 months have
lapsed since the Registrable Securities were acquired from the Company as calculated in accordance
with Rule 144).

     “Registrable Securities then outstanding” shall be the number of shares determined by
calculating the total number of shares of Common Stock that are Registrable Securities issued and
outstanding.

     “Registration Expenses” shall mean all expenses incurred by the Company in effecting
any registration pursuant to this Agreement (including any Mandatory Registration or Shelf
Registration), including, without limitation, all registration and filing fees, printing expenses,
fees and disbursements of counsel for the Company, blue sky fees and expenses, and expenses of the
Company’s independent accountants in connection with any regular or special reviews or audits
incident to or required by any such registration, and fees and expenses of underwriters (excluding
discounts and commissions) and any other Persons retained by the Company, but shall not include
Selling Expenses, certain fees and disbursements of counsel for the Holders (except as set forth
below) and the compensation of regular employees of the Company, which shall be paid in any event
by the Company.

     “SEC” or “Commission” means the Securities and Exchange Commission and any
successor agency.

2

 

     “Securities Act” shall mean the Securities Act of 1933, as amended, or similar federal
statute, and the rules and regulations of the Commission thereunder, all as the same shall be in
effect at the time.

     “Selling Expenses” shall mean all underwriting discounts, selling commissions, fees of
underwriters, selling brokers, dealer managers and similar securities industry professionals and
stock transfer taxes applicable to the sale of Registrable Securities and fees and disbursements of
counsel for any Holder (other than the fees and disbursements of counsel included in Registration
Expenses).

     “Shares” mean shares of Common Stock issued by the Company to the Purchasers pursuant
to the Stock Purchase Agreement.

     “Shelf Registration” shall have the meaning ascribed to it in Section 2.1(a) hereof.

     “Shelf Termination Date” shall have the meaning ascribed to it in Section 2.1(a)
hereof.

     “Trading Day” means a day on which the principal securities exchange or automated
quotation system upon which the Registrable Securities are then listed for public trading) shall be
open for business.

     “Violation” shall have the meaning ascribed to it in Section 2.7(a) hereof.

SECTION 2.

REGISTRATION

     2.1 Shelf Registration

          (a) In accordance with the requirements of Section 2.3 below, the Company shall use its
commercially reasonable efforts to file with the SEC, and to cause to be declared effective by the
SEC, a registration statement on the applicable SEC form with respect to the resale from time to
time, whether underwritten or otherwise, of the Registrable Securities by the Holders thereof. The
Company shall also use its commercially reasonable efforts to maintain the effectiveness of the
registration effected pursuant to this Section 2.1 and keep such registration statement free of any
material misstatements or omissions at all times, subject only to the limitations on effectiveness
set forth below. The registration contemplated by this Section 2.1 is referred to herein as the
“Mandatory Registration.” The Mandatory Registration shall be filed with the SEC in accordance
with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in
effect) (a “Shelf Registration”). The Company shall use its commercially reasonable efforts to
cause the registration statement filed on Form S-3 or any similar short-form registration as the
Company may elect to remain effective until such date (the “Shelf Termination Date”) as is the
earlier of (i) the date on which all Registrable Securities included in the registration statement
shall have been sold or shall have otherwise ceased to be Registrable Securities and (ii) the date
on which all remaining Registrable Securities may be sold pursuant to Rule 144(c)(l) and otherwise
without restriction or limitation pursuant to Rule 144 (or any successor thereto) under the
Securities Act, after taking into account any Holders’ status as an Affiliate of the Company as
determined by counsel to the Company pursuant to a written opinion letter addressed to the
Company’s transfer agent to such effect (provided at least 12

3

 

months have lapsed since the Registrable Securities were acquired from the Company as
calculated in accordance with Rule 144). If the Company is not then eligible to register for
resale the Registrable Securities on Form S-3, such registration shall be on another appropriate
form in accordance herewith. In the event the Mandatory Registration must be effected on Form S-1
or any similar long-form registration statement as the Company may elect, the Company shall use
commercially reasonable efforts to file such registration statement as a Shelf Registration and the
Company shall use its commercially reasonable efforts to keep such registration current and
effective, including by filing periodic post-effective amendments until the Shelf Termination Date
to update the financial statements contained in such registration statement in accordance with
Regulation S-X promulgated under the Securities Act and to update the names and other information
regarding the Holders contained in such registration statement in accordance with the Securities
Act. By 9:30 a.m. on the Trading Day immediately following the effective date of the applicable
registration statement, the Company shall file with the Commission in accordance with Rule 424
under the Securities Act the final prospectus to be used in connection with sales pursuant to such
registration statement.

          (b) In no event shall the Company include securities, whether on behalf of itself or any other
person, other then the Registrable Securities on any registration statement filed pursuant to this
Section 2.

          (c) Notwithstanding anything to the contrary contained in this Agreement, in the event the
Commission seeks to characterize any offering pursuant to a Mandatory Registration filed pursuant
to this Agreement as constituting an offering of securities by or on behalf of the Company, or in
any other manner, such that the Commission does not permit such registration statement to become
effective and used for resales in a manner that does not constitute such an offering and that
permits the continuous resale at the market by the Holders participating therein (or as otherwise
may be acceptable to each Holder) without being named therein as an “underwriter,” then the Company
shall reduce the number of shares to be included in such registration statement until such time as
the Commission shall so permit such registration statement to become effective as aforesaid. In
making such reduction, the Company shall then reduce the number of shares to be included by all
Holders of Registrable Securities on a pro rata basis (based upon the number of Registrable
Securities otherwise required to be included for each such Holder). As soon as reasonably
practicable thereafter (as permitted by the Commission), the Company shall register the additional
Registrable Securities on such additional registration statements as may be required to register
the resale of all of the Registrable Securities (to the extent it can without causing the foregoing
problem). In no event shall a Holder be required to be named as an “underwriter” in a registration
statement without such Holder’s prior written consent.

     2.2 Expenses of Registration. All reasonable Registration Expenses incurred in
connection with any registration, qualification or compliance hereunder shall be borne by the
Company. All Selling Expenses incurred in connection with any registrations hereunder, shall be
borne by the Holders of the Registrable Securities so registered pro rata on the basis of the
number of shares so registered.

     2.3 Additional Obligations of the Company. The Company shall:

4

 

          (a) Within thirty (30) days following the Closing Date, use commercially reasonable efforts to
prepare and file with the SEC a registration statement on Form S-3, and all amendments and
supplements thereto and related prospectuses as may be necessary to comply with applicable
securities laws, with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective within one hundred-twenty (120)
days of the Closing Date (provided that at least three (3) Trading Days before filing a
registration statement or prospectus or any amendments or supplements thereto, the Company shall
furnish to the counsel selected by the Holders of a majority of the Registrable Securities covered
by such registration statement copies of all such documents proposed to be filed, and the Company
shall in good faith consider any reasonable comments of such counsel).

          (b) Promptly notify the Holders (i) when the Company has been notified by the Commission
whether or not a registration statement or any amendment thereto will be subject to a review by the
Commission and (ii) if reviewed, when the Company has been notified by the Commission that a
registration statement or amendment thereto will not be subject to further review. Upon the
request of a Holder, the Company shall provide such Holder true and complete copies of all
correspondence from and to the Commission relating to a registration statement (with all material,
non-public information regarding the Company redacted from such copies). The Company shall respond
as promptly as reasonably practicable to any comments received from the Commission with respect to
the registration statement or any amendments thereto. The Company shall promptly file with the
Commission a request for acceleration of effectiveness in accordance with Rule 461 promulgated
under the Securities Act after the Company is notified (orally or in writing, whichever is earlier)
by the Commission that a registration statement will not be reviewed, or will not be subject to
further review, such that the Registration Statement shall be declared effective no later than
seven (7) Trading Days after such notification.

          (c) Furnish to the Purchasers and Holders such number of copies of a prospectus, including a
preliminary prospectus, in conformity with the requirements of the Securities Act, and such other
documents as they may reasonably request in order to facilitate the disposition of Registrable
Securities owned by them.

          (d) Use its commercially reasonable efforts to register and qualify the securities covered by
such registration statement under such other securities or Blue Sky laws of such jurisdictions as
shall be reasonably requested by the Holders unless an exemption from registration and
qualification exists; provided that the Company shall not be required in connection therewith or as
a condition thereto to qualify to do business, file a general consent to service of process or
subject itself to general taxation in any such states or jurisdictions.

          (e) In the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing underwriter(s) of
such offering. Each Purchaser and/or Holder participating in such underwriting shall also enter
into and perform its obligations under such an agreement.

          (f) Promptly notify each Purchaser who holds, and each Holder of Registrable Securities
covered by the registration statement at any time when a prospectus relating thereto is required to
be delivered under the Securities Act of the happening of any event as a result of which the
prospectus included in such registration statement, as then in effect, includes an untrue

5

 

statement of a material fact or omits to state a material fact required to be stated therein
or necessary to make the statements therein not misleading in light of the circumstances then
existing (provided that in no event shall such notice contain any material, non-public information
regarding the Company) and, the Company shall promptly prepare and furnish to each such Holder a
reasonable number of copies of a supplement or amendment to such prospectus so that, as thereafter
delivered to the purchasers of such Registrable Securities, such prospectus shall not contain an
untrue statement of a material fact or omit to state a fact necessary to make the statements
therein not misleading in light of the circumstances under which they were made.

          (g) Use its commercially reasonable efforts to furnish, on the date that such Registrable
Securities are delivered to the underwriters for sale or the date of the applicable offering
document, as applicable, if such securities are being sold through underwriters, (i) an opinion,
dated as of the date such Registrable Securities are delivered to the underwriters for sale, of the
counsel representing the Company for the purposes of such registration, in form and substance as is
customarily given to underwriters in an underwritten public offering, addressed to the
underwriters, if any, and (ii) a letter dated as of the date of the applicable offering document,
from the independent registered public accountants of the Company, in form and substance as is
customarily given by independent registered public accountants to underwriters in an underwritten
public offering addressed to the underwriters.

          (h) Use its commercially reasonable efforts to (i) prevent the issuance of any stop order or
other suspension of effectiveness of a registration statement, or the suspension of the
qualification of any of the Registrable Securities for sale in any jurisdiction in the United
States, and (ii) in the event of the issuance of any stop order suspending the effectiveness of a
registration statement, or any order suspending or preventing the use of any related prospectus or
suspending the qualification of any equity securities included in such registration statement for
sale in any jurisdiction, the Company shall use its commercially reasonable efforts promptly to
obtain the withdrawal of such order.

          (i) Use its commercially reasonable best efforts to cause all Shares to be listed on each
securities exchange (including the NASDAQ Global Select Stock Market) on which similar securities
issued by the Company are then listed.

          (j) Use its commercially reasonable efforts to cooperate with the Holders who hold Registrable
Securities being offered and, to the extent applicable, facilitate the timely preparation and
delivery of certificates (not bearing any restrictive legend) representing the Registrable
Securities to be offered pursuant to a Registration Statement and enable such certificates to be in
such denominations or amounts, as the case may be, as the Holders may reasonably request and,
registered in such names as the Holders may request.

          (k) Provide and cause to be maintained a registrar and transfer agent for all Registrable
Securities covered by any registration statement from and after a date not later than the effective
date of such registration statement.

          (l) Use its commercially reasonable efforts to maintain eligibility to use Form S-3 (or any
successor form thereto) for the registration of the resale of the Registrable Securities.

6

 

          (m) Not, nor shall any subsidiary or affiliate thereof, identify any Purchaser as an
underwriter in any public disclosure or filing with the SEC or the NASDAQ Global Select Market or
any other securities exchange or market and any Purchaser being deemed an underwriter by the SEC
shall not relieve the Company of any obligations it has under this Agreement or the Stock Purchase
Agreement.

     2.4 Suspension of Sales. Upon receipt of written notice from the Company that the
registration statement or a prospectus contains an untrue statement of a material fact or omits to
state a material fact required to be stated therein or necessary to make the statements therein not
misleading (a “Misstatement”), each Purchaser who holds, and each Holder of Registrable Securities
shall forthwith discontinue disposition of Registrable Securities until such Purchaser and/or
Holder has received copies of the supplemented or amended prospectus that corrects such
Misstatement, or until such Purchaser and/or Holder is advised in writing by the Company that the
use of the prospectus may be resumed, and, if so directed by the Company, such Purchaser and/or
Holder shall deliver to the Company all copies, other than permanent file copies then in such
Purchaser’s or Holder’s possession, of the prospectus covering such Registrable Securities current
at the time of receipt of such notice. The Company will not suspend the sales under the prospectus
more than two times in any three hundred-sixty-five (365) day period and the total number of days
that any such suspension may be in effect in any three hundred-sixty-five (365) day period shall
not exceed 45 days.

     2.5 Termination of Registration Rights. A Purchaser’s and a Holder’s registration
rights shall expire if all Registrable Securities held by such Purchaser or Holder (and its
Affiliates, partners, members and former members) may be sold pursuant to Rule 144 without the
requirement to be in compliance with Rule 144(c)(l) and otherwise without restriction or limitation
pursuant to Rule 144 (or any successor thereto) under the Securities Act, after taking into account
any Holder’s status as an Affiliate of the Company, as a result of the amount of shares of the
Company’s Common Stock then owned by such Holder as a percentage of the Company’s outstanding
shares of Common Stock, as determined by counsel to the Company pursuant to a written opinion
letter addressed to the Company’s transfer agent to such effect (provided at least 12 months have
lapsed since the Registrable Securities were acquired from the Company, as calculated in accordance
with Rule 144). Termination of such registration rights shall be conditioned upon the Company’s
action to remove the restrictive legends from any Registrable Securities held by such Purchaser or
Holder, provided that such Purchaser or Holder is not an Affiliate of the Company, and the
reissuance of unlegended certificates, in physical or electronic format, to such Purchaser or
Holder.

     2.6 Furnishing Information. It shall be a condition precedent to the obligations of
the Company to take any action pursuant to Section 2.1 or 2.3 that the selling Purchasers and/or
Holders shall furnish to the Company such information regarding themselves, the Registrable
Securities held by them and the intended method of disposition of such securities as shall be
required to effect the registration of their Registrable Securities.

     2.7 Indemnification. In the event any Registrable Securities are included in a
registration statement under this Section 2:

7

 

          (a) To the extent permitted by law, the Company will indemnify and hold harmless each
Purchaser, Holder, any underwriter (as defined in the Securities Act) for such Purchaser or Holder
and each person, if any, who controls such Purchaser or Holder or underwriter within the meaning of
the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint
or several) to which they may become subject under the Securities Act, or the Exchange Act or other
federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in
respect thereof) arise out of or are based upon any of the following statements, omissions or
violations (collectively, a “Violation”): (i) any untrue statement or alleged untrue statement of
a material fact contained in such registration statement, including any related preliminary
prospectus or final prospectus or any amendments or supplements thereto, (ii) the omission or
alleged omission to state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation or alleged violation by the
Company of the Securities Act, the Exchange Act, any other federal or state securities law or any
rule or regulation promulgated under the Securities Act, the Exchange Act or any other federal or
state securities law in connection with the registration of the Registrable Securities; and the
Company will pay to each such Purchaser, Holder, underwriter or controlling person, as accrued any
legal or other expenses reasonably incurred by them in connection with investigating or defending
any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement
contained in this Section 2.7(a) shall not apply to amounts paid in settlement of any such loss,
claim, damage, liability, or action if such settlement is effected without the consent of the
Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any
such case for any such loss, claim, damage, liability, or action to the extent that it arises out
of or is based upon a Violation which occurs in reliance upon and in conformity with written
information furnished expressly for use in connection with such registration statement by any such
Purchaser, Holder, underwriter or controlling person or any failure of such person to deliver or
cause to be delivered a prospectus made available by the Company in a timely manner.

          (b) To the extent permitted by law and provided that such Holder is not entitled to
indemnification pursuant to Section 2.7(a) above with respect to such matter, each selling
Purchaser or Holder (severally and not jointly) will indemnify and hold harmless the Company, each
of its directors, officers, persons, if any, who control the Company within the meaning of the
Securities Act, any underwriter, any other Purchaser or Holder selling securities in such
registration statement and any controlling person of any such underwriter or other Purchaser or
Holder, against any losses, claims, damages, or liabilities to which any of the foregoing persons
may become subject under the Securities Act, the Exchange Act or other federal or state law,
insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out
of or are based upon any (i) untrue statement or alleged untrue statement of a material fact
regarding such Holder and provided in writing by such Holder which is contained in such
registration statement, including any related preliminary prospectus or final prospectus or any
amendments or supplements thereto or (ii) the omission or alleged omission to state therein a
material fact required to be stated therein, or necessary to make the statements therein not
misleading, in each case to the extent (and only to the extent) that such untrue statement or
alleged untrue statement or omission or alleged omission was made in such registration statement,
preliminary or final prospectus, amendment or supplement thereto, in reliance upon and in
conformity with written information furnished by such Purchaser or Holder expressly for use in
connection with such registration statement; and each such Purchaser or Holder will pay,

8

 

as accrued, any legal or other expenses reasonably incurred by any Person intended to be
indemnified pursuant to this Section 2.7(b), in connection with investigating or defending any such
loss, claim, damage, liability, or action as a result of such Holder’s untrue statement or
omission; provided, however, that the indemnity agreement contained in this Section 2.7(b) shall
not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if
such settlement is effected without the consent of the Purchaser or Holder (which consent shall not
be unreasonably withheld); provided, that, (x) the indemnification obligations in this Section
2.7(b) shall be individual and ratable not joint and several for each Holder and (y) in no event
shall the aggregate of all indemnification payments by any Purchaser and/or Holder under this
Section 2.7(b) exceed the net proceeds from the offering received by such Purchaser and/or Holder.

          (c) Promptly after receipt by an indemnified party under this Section 2.7 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 2.7,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying
party shall have the right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an indemnified party
(together with all other indemnified parties which may be represented without conflict by one
counsel) shall have the right to retain one separate counsel, with the reasonable fees and expenses
of such counsel to be paid by the indemnifying party, if (i) the indemnifying party shall have
failed to assume the defense of such claim within seven (7) days after receipt of notice of the
claim and to employ counsel reasonably satisfactory to such indemnified party, as the case may be;
or (ii) in the reasonable opinion of counsel retained by the indemnifying party, representation of
such indemnified party by such counsel would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such counsel in such
proceeding. The indemnified party shall cooperate fully with the indemnifying party in connection
with any negotiation or defense of any such action or claim by the indemnifying party and shall
furnish to the indemnifying party all information reasonably available to the indemnified party
which relates to such action or claim. The indemnifying party shall beep the indemnified party
reasonably apprised of the status of the defense or any settlement negotiations with respect
thereto. No indemnifying party shall be liable for any settlement of any action, claim or
proceeding effected without its prior written consent; provided, however, that the indemnifying
party shall not unreasonably withhold, delay or condition its consent. The failure to deliver
written notice to the indemnifying party within a reasonable time of the commencement of any such
action shall not relieve such indemnifying party of any liability to the indemnified party under
this Section 2.7, except to the extent such failure to give notice has a material adverse effect on
the ability of the indemnifying party to defend such action.

          (d) If the indemnification provided for in this Section 2.7 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim,
damage, or expense referred to therein, then the indemnifying party, in lieu of indemnifying such
indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand

9

 

and of the indemnified party on the other in connection with the statements or omissions that
resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the indemnified party shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access
to information, and opportunity to correct or prevent such statement or omission. Notwithstanding
the foregoing, the amount any Purchaser or Holder will be obligated to contribute pursuant to this
Section 2.7(d) will be limited to an amount equal to the per share public offering price (less any
underwriting discount and commissions) multiplied by the number of shares of Registrable Securities
sold by such Purchaser or Holder pursuant to the registration statement which gives rise to such
obligation to contribute (less the aggregate amount of any damages which such Purchaser or Holder
has otherwise been required to pay in respect of such loss, liability, claim, damage, or expense or
any substantially similar loss, liability, claim, damage, or expense arising from the sale of such
Registrable Securities). No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) will be entitled to contribution hereunder from any person who
was not guilty of such fraudulent misrepresentation.

          (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control; provided that the indemnification provisions of the Holders
in any underwriting agreement may not conflict with the provisions of this Section 2.7 without the
consent of the affected Holders.

          (f) The obligations of the Company and Holders under this Section 2.7 shall survive the
completion of any offering of Registrable Securities in a registration statement under this Section
2, and otherwise.

     2.8 Assignment of Registration Rights. The rights to cause the Company to register
Registrable Securities pursuant to this Agreement may be assigned by an Purchaser or Holder to a
transferee or assignee of Registrable Securities to which (a) such transferee is an investment
advisory client, Affiliate, subsidiary or parent company, family member or family trust for the
benefit of a party hereto, (b) such transferee shares a common discretionary investment advisor
with such Purchaser or Holder, or (c) such transferee or transferees are partners or members of an
Purchaser or Holder, who agree to act through a single representative; provided, however, (i) the
transferor shall furnish to the Company written notice of the name and address of such transferee
or assignee and the securities with respect to which such registration rights are being assigned
and (ii) such transferee shall agree to be subject to all restrictions set forth in this Agreement.

     2.9 Rule 144 Reporting. With a view to making available to the Purchasers and Holders
the benefits of certain rules and regulations of the SEC which may permit the sale of the
Registrable Securities to the public without registration, the Company agrees to use its
commercially reasonable efforts to:

10

 

          (a) make and keep public information available, as those terms are understood and defined in
SEC Rule 144 or any similar or analogous rule promulgated under the Securities Act, at all times
after the effective date of this Agreement;

          (b) file with the SEC, in a timely manner, all reports and other documents required of the
Company under the Exchange Act; and

          (c) so long as an Purchaser or Holder owns any Registrable Securities, furnish to such
Purchaser or Holder forthwith upon request a written statement by the Company as to its compliance
with the reporting requirements of Rule 144 under the Securities Act, and of the Exchange Act; a
copy of the most recent annual or quarterly report of the Company; and such other reports and
documents as an Purchaser or Holder may reasonably request in availing itself of any rule or
regulation of the SEC allowing it to sell any such securities without registration.

     2.10 Obligations of the Holders

          (a) Each Holder shall furnish in writing to the Company such information regarding itself, the
Registrable Securities held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the registration of such
Registrable Securities and shall execute such documents in connection with such registration as the
Company may reasonably request in connection therewith, upon the execution of this Agreement, each
Holder shall complete, execute and deliver to the Company a selling securityholder notice and
questionnaire in form reasonably satisfactory to the Company. At least five (5) business days
prior to the first anticipated filing date of any Registration Statement, the Company shall notify
each Holder of any additional information the Company requires from such Holder if such Holder
elects to have any of the Registrable Securities included in the Registration Statement. A Holder
shall provide such information to the Company at least two (2) business days prior to the first
anticipated filing date of such Registration Statement if such Holder elects to have any of the
Registrable Securities included in the Registration Statement.

          (b) Each Holder, by its acceptance of the Registrable Securities agrees to cooperate with the
Company as reasonably requested by the Company in connection with the preparation and filing of a
Registration Statement hereunder, unless such Holder has notified the Company in writing of its
election to exclude all of its Registrable Securities from such Registration Statement.

          (c) Each Holder covenants and agrees that it shall comply with the prospectus delivery
requirements of the Securities Act as applicable to it in connection with sales of Registrable
Securities pursuant to any Registration Statement.

SECTION 3.

MISCELLANEOUS

     3.1 Successors and Assign. Except as otherwise provided herein, the terms and
conditions of this Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties (including transferees of any shares of Registrable
Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party
other than the parties hereto or their respective successors and assigns any rights, remedies,

11

 

obligations, or liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.

     3.2 Governing Law. All questions concerning the construction, validity, enforcement
and interpretation of this Agreement shall be governed by the internal laws of the State of
Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether
of the State of Delaware or any other jurisdictions) that would cause the application of the laws
of any jurisdictions other than the State of Delaware.

     3.3 Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument

     3.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement

     3.5 Notices. Unless otherwise provided, any notice required or permitted under this
Agreement shall be given in writing and shall be deemed effectively given upon personal delivery to
the party to be notified or upon deposit with the United States Post Office, by registered or
certified mail, postage prepaid and addressed to the party to be notified at the address indicated
for such party on the signature page hereof, or at such other address as such party may designate
by ten (10) days’ advance written notice to the other parties.

     3.6 Expenses. If any action at law or in equity is necessary to enforce or interpret
the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees,
costs and necessary disbursements in addition to any other relief to which such party may be
entitled.

     3.7 Amendments and Waivers. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively), only with the written consent of the Company
and the holders of a majority of the Registrable Securities then outstanding. Any amendment or
waiver effected in accordance with this paragraph shall be binding upon each Holder of any
Registrable Securities then outstanding, each future Holder of all such Registrable Securities, and
the Company. No such amendment shall be effective to the extent that it applies to less than all
of the holders of the Registrable Securities. No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless
the same consideration also is offered to all of the parties to this Agreement.

     3.8 Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision shall be excluded from this Agreement and the
balance of the Agreement shall be interpreted as if such provision were so excluded and shall be
enforceable in accordance with its terms.

     3.9 Aggregation of Stock. All shares of Registrable Securities held or acquired by
any Purchasers which are Affiliates shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement.

12

 

     3.10 Entire Agreement. This Agreement constitutes the full and entire understanding
and agreement between the parties with regard to the subject matter hereof.

[SIGNATURE PAGE FOLLOWS]

13

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date set forth
herein.

	 	 	 	 	 	 	 
	 	 	TEXAS CAPITAL BANCSHARES, INC.
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:
	 	George F. Jones, Jr.	 	 
	 

	 	Title:
	 	President and Chief Executive Officer	 	 
	 
	 	 	 	 	 	 
	 

	 	Address:
	 	2100 McKinney, Suite 900	 	 
	 

	 	 	 	Dallas, Texas 75201	 	 

 

 

Investor Counterpart Signature Page to

Registration Rights Agreement

	 	 	 	 	 
	 	

 	 
	 
	 	By:  	 	 
	 	 	Name:  	__________________________ 	 
	 	 	Title:  	___________________________ 	 
	 

	 	 	 	 	 	 	 	 	 
	 

	 	Address:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	Fax No.exv10w1

Exhibit 10.1

Execution Version

CONSENT

AND

AMENDMENT No. 3

TO

SECOND AMENDED AND RESTATED LOAN AGREEMENT

     This CONSENT AND AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (this
“Amendment”) is made and entered into as of the 2d day of September, 2008, by and among
NATIONAL DENTEX CORPORATION, a Massachusetts corporation (“Dentex”), its Subsidiaries
listed on the signature page(s) hereto (together with Dentex, collectively the
“Borrowers”), and BANK OF AMERICA, N.A. (the “Bank”). Capitalized terms used
herein without definition shall have the meaning ascribed to them in the Loan Agreement (as defined
below).

     WHEREAS, the Borrowers and the Bank are parties to that certain Second Amended and Restated
Loan Agreement dated as of November 7, 2006, as amended by that certain Loan Modification Agreement
dated as of March 29, 2007, that certain Amendment to Second Amended and Restated Loan Agreement
dated as of October 24, 2007, and that certain Amendment No. 2 to Second Amended and Restated Loan
Agreement dated as of May 9, 2008 (collectively, as the same may be hereby and further amended and
in effect from time to time, the “Loan Agreement”), pursuant to which the Bank has extended
credit to the Borrowers on the terms set forth therein;

     WHEREAS, the Borrowers have requested the Bank to consent to the proposed acquisition of 100%
of the stock of Dental Art Laboratories, Inc. (“Dental Art”), for a purchase price of up to
$10,000,000 plus adjustments in accordance with the terms and conditions of the subject stock
purchase agreement (the “Acquisition”);

     WHEREAS, the Borrowers have requested the Bank to modify the Maximum Consolidated Total Funded
Debt to Consolidated EBITDA covenant set forth in Section 6(u) of the Loan Agreement as applicable
to the period ending September 30, 2008;

     WHEREAS, the Bank is willing to grant such consent and to modify the Loan Agreement as
requested on the terms and conditions set forth herein.

     NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby
agree as follows:

     1. Consent. The Bank hereby consents to the Acquisition.

 

 

     2. Amendment to §6(u) of the Loan Agreement. Section 6(u) of the Loan Agreement is
hereby amended by deleting such Section in its entirety and replacing it with the following:

     “(u) Maximum Consolidated Total Funded Debt to Consolidated EBITDA. As of the end of any
fiscal quarter, the ratio of (a) Consolidated Total Funded Debt as of such date to (b) Consolidated
EBITDA for the period of four (4) consecutive fiscal quarters ending on the date of calculation (i)
prior to and including June 30, 2008, shall not exceed 2.5:1.00; (ii) as of September 30, 2008,
shall not exceed 2.75:1.00; (iii) as of December 31, 2008, shall not exceed 2.5:1.00; and (iv)
thereafter shall not exceed 2.0:1.00.”

     3. Effective Dates and Conditions to Effectiveness. The consent and waivers
hereunder shall be effective as of the date hereof upon the receipt by the Bank of a counterpart
signature page to this Amendment duly executed and delivered by each of the Borrowers.

     4. Representations and Warranties. Each of the Borrowers represents and warrants as
follows:

     (a) The execution and delivery of this Amendment and the performance of each of this Amendment
and the Loan Agreement, as amended as of the date hereof, are within the corporate power and
authority of such Borrower and have been or will be authorized by proper corporate proceedings, and
do not (i) require any consent or approval of the stockholders of such Borrower, (ii) contravene
any provision of the charter documents or by-laws of such Borrower or any law, rule or regulation
applicable to such Borrower, or (iii) contravene any provision of, or constitute an event of
default or event which, but for the requirement that time elapse or notice be given, or both, would
constitute an event of default under, any other material agreement, instrument or undertaking
binding on such Borrower.

     (b) This Amendment and the Loan Agreement, as amended as of the date hereof, and all of the
terms and provisions hereof and thereof are the legal, valid and binding obligations of such
Borrower enforceable in accordance with their respective terms except as limited by bankruptcy,
insolvency, reorganization, moratorium or other laws affecting the enforcement of creditors’ rights
generally, and except as the remedy of specific performance or of injunctive relief is subject to
the discretion of the court before which any proceeding therefor may be brought.

     (c) Except with respect to filings with the U.S. Securities and Exchange Commission, the
execution, delivery and performance of this Amendment, as of the date hereof, do not require any
approval or consent of, or filing or registration with, any governmental or other agency or
authority, or any other party.

     (d) Each of the representations and warranties of the Borrowers contained in the Loan
Agreement (after giving effect to this Amendment) or in any document or

2

 

instrument delivered pursuant to or in connection with the Loan Agreement are true and correct
in all material respects as of the date hereof with the same effect as if made on and as of the
date hereof (except to the extent of changes resulting from transactions contemplated or permitted
by the Loan Agreement and changes occurring in the ordinary course of business which singly or in
the aggregate do not create a Material Adverse Effect, and to the extent that such representations
and warranties relate expressly to an earlier date).

     (e) After giving effect to this Amendment, no Default or Event of Default under the Loan
Agreement has occurred and is continuing.

     (f) The consideration paid in connection with the Acquisition shall not exceed $10,000,000
plus adjustments in accordance with the terms and conditions of the subject stock purchase
agreement.

     (g) In connection with and in no event later than 30 days after the effective date of the
Acquisition, Dental Art shall be merged into Dentex.

     5. Ratification, etc. Except as expressly amended hereby, the Loan Agreement, the
other Loan Documents and all documents, instruments and agreements related thereto are hereby
ratified and confirmed in all respects and shall continue in full force and effect. Each Borrower
hereby affirms all of its obligations under the Loan Agreement and under each of the other Loan
Documents to which it is a party and hereby affirms its absolute and unconditional promise to pay
to the Bank the Loans and all other amounts due under the Loan Agreement (as amended hereby) and
the other Loan Documents. This Amendment and the Loan Agreement shall hereafter be read and
construed together as a single document, and all references in the Loan Agreement or any related
agreement or instrument to the Loan Agreement shall hereafter refer to the Loan Agreement as
amended by this Amendment.

     6. Governing Law. This Amendment and the rights and obligations of the parties
hereunder shall be deemed to be a document executed under seal and shall be construed and
interpreted in accordance with the laws of the Commonwealth of Massachusetts (excluding the laws
applicable to conflicts or choice of law).

     7. Delivery By Facsimile Or Other Electronic Transmission. This Agreement, to the
extent signed and delivered by means of a facsimile machine or other electronic transmission in
which the actual signature is evident, shall be treated in all manner and respects as an original
agreement or instrument and shall be considered to have the same binding legal effect as if it were
the original signed version thereof delivered in person. At the request of any party hereto, each
other party hereto or thereto shall re-execute original forms hereof and deliver them to all other
parties. No party hereto shall raise the use of a facsimile machine or other electronic
transmission in which the actual signature is evident to deliver a signature or the fact that any
signature or agreement or instrument was transmitted or

3

 

communicated through the use of a facsimile machine or other electronic transmission in which
the actual signature is evident as a defense to the formation of a contract and each party forever
waives such defense.

     8. Counterparts. This Agreement may be executed in any number of counterparts and by
different parties hereto on separate counterparts, each of which when so executed and delivered
shall be an original, but all of which counterparts taken together shall be deemed to constitute
one and the same instrument.

[Remainder of page intentionally blank]

4

 

     IN WITNESS WHEREOF, the undersigned have duly executed this Amendment as of the date first set
forth above.

	 	 	 	 	 	 	 
	NATIONAL DENTEX CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Richard F. Becker, Jr.
 

Richard F. Becker, Jr.
	 	 
	 

	 	Title:
	 	Executive Vice President and Treasurer	 	 
	 
	 	 	 	 	 	 
	GREEN DENTAL LABORATORIES, INC.,	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Richard F. Becker, Jr.
 

Richard F. Becker, Jr.
	 	 
	 

	 	Title:
	 	Assistant Treasurer	 	 
	 
	 	 	 	 	 	 
	KELLER GROUP, INCORPORATED	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Richard F. Becker, Jr.
 

Richard F. Becker, Jr.
	 	 
	 

	 	Title:
	 	Assistant Treasurer and Assistant Secretary	 	 
	 
	 	 	 	 	 	 
	KELLER LABORATORIES, INCORPORATED — MIDWEST	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Richard F. Becker, Jr.
 

Richard F. Becker, Jr.
	 	 
	 

	 	Title:
	 	Assistant Treasurer and Assistant Secretary	 	 
	 
	 	 	 	 	 	 
	KELLER LABORATORIES, INC. — SOUTHEAST	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Richard F. Becker, Jr.
 

Richard F. Becker, Jr.
	 	 
	 

	 	Title:
	 	Assistant Treasurer and Assistant Secretary	 	 

Consent and Amendment No 3 Borrower Signature Page

 

 

	 	 	 	 	 	 	 
	BANK OF AMERICA, N.A.,

as the Bank	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Richard J. MacDonald
 

Richard J. MacDonald
	 	 
	 

	 	Title:
	 	Vice President	 	 

Consent
and Amendment No 3 Bank Signature Page

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]